# HH BIOTECHNOLOGY HOLDINGS CO

HH BIOTECHNOLOGY HOLDINGS CO is a company headquartered in Heping District, Shenyang, China.

## Company overview

- **Legal name:** HH BIOTECHNOLOGY HOLDINGS CO
- **Former names in filing history:** GREAT CHINA INTERNATIONAL HOLDINGS, INC. (2005-07-29 to 2016-08-24); RED HORSE ENTERTAINMENT CORP (1997-08-22 to 2005-11-15)
- **Classification:** Company
- **Industry (SIC):** 6500 — Real Estate
- **Headquarters:** Heping District, Shenyang, China
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0000828878

## About

HH BIOTECHNOLOGY HOLDINGS CO is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000828878, and its reported industry is Real Estate. In 10-K filed on 2016-04-14, it reported annual revenue of USD 7,990,073; net income of USD 2,424,394; total assets of USD 46,461,059 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $8.0M (USD 7,990,073)
- **Net income:** $2.4M (USD 2,424,394)
- **Total assets:** $46.5M (USD 46,461,059)
- **Cash and equivalents:** $9.8M (USD 9,819,260)
- **Operating cash flow:** $3.6M (USD 3,573,466)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $8.0M (USD 7,986,192)
- **Net income:** -$4.3M (USD -4,313,420)
- **Total assets:** $54.0M (USD 53,984,409)
- **Cash and equivalents:** $8.8M (USD 8,799,261)
- **Operating cash flow:** $1.7M (USD 1,685,766)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $7.7M (USD 7,694,913)
- **Net income:** -$1.8M (USD -1,814,398)
- **Total assets:** $59.6M (USD 59,555,164)
- **Cash and equivalents:** $7.1M (USD 7,115,476)
- **Operating cash flow:** $1.7M (USD 1,692,781)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $7.4M (USD 7,351,786)
- **Net income:** -$2.3M (USD -2,326,526)
- **Total assets:** $59.4M (USD 59,434,635)
- **Cash and equivalents:** $5.9M (USD 5,927,618)
- **Operating cash flow:** $765,571 (USD 765,571)

## Recent SEC filings

- Form 8-K — filed 2016-12-27 — period 2016-12-20 — CURRENT REPORT
- Form 8-K — filed 2016-11-22 — period 2016-11-18 — CURRENT REPORT
- Form 10-Q — filed 2016-11-14 — period 2016-09-30 — FORM 10-Q ENDED SEPTEMBER 30, 2016
- Form 8-K — filed 2016-09-13 — period 2016-09-09 — FORM 8-K DATED SEPTEMBER 9, 2016
- Form 8-K — filed 2016-08-24 — period 2016-08-23 — FORM 8-K DATED AUGUST 23, 2016
- Form 10-Q — filed 2016-08-15 — period 2016-06-30 — FORM 10-Q ENDED JUNE 30, 2016
- Form 8-K — filed 2016-08-02 — period 2016-07-27 — FORM 8-K DATED JULY 27, 2016
- Form 8-K — filed 2016-07-08 — period 2016-07-01 — FORM 8-K DATED JULY 1, 2016
- Form 8-K — filed 2016-06-10 — period 2016-06-06 — FORM 8-K DATED JUNE 6, 2016
- Form 8-K — filed 2016-05-18 — period 2016-05-15 — FORM 8-K DATED MAY 15, 2016
- Form 10-Q — filed 2016-05-16 — period 2016-03-31 — FORM 10-Q ENDED MARCH 31, 2016
- Form 10-K — filed 2016-04-14 — period 2015-12-31 — FORM 10-K YEAR ENDED DECEMBER 31, 2015

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/hh-biotechnology-holdings-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology